Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longevity of microwave thermolysis versus botulinum toxin A for axillary hyperhidrosis
2021-000877-10Phase 4Completed
- Sponsor
- Bispebjerg and Frederiksberg Hospital
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in axillary hyperhidrosis and hyperhidrosis (2 arms), sponsored by Bispebjerg and Frederiksberg Hospital. Primary endpoint: Axillary sweat reduction at 6 months. Started Mar 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
axillary hyperhidrosishyperhidrosis
Beyond the preview
Go deeper on 2021-000877-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000877-10.